|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JY, Kim HS, Suh DH, Kim MK, Chung HH
and Song YS: Ovarian cancer biomarker discovery based on genomic
approaches. J Cancer Prev. 18:298–312. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suh DH, Kim MK, Kim HS, Chung HH and Song
YS: Epigenetic therapies as a promising strategy for overcoming
chemoresistance in epithelial ovarian cancer. J Cancer Prev.
18:227–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng H, Liu JY, Song FJ and Chen KX:
Advances in circulating microRNAs as diagnostic and prognostic
markers for ovarian cancer. Cancer Biol Med. 10:123–130.
2013.PubMed/NCBI
|
|
5
|
Lin JY, Qin JB, Li XY, Dong P and Yin BD:
Diagnostic value of human epididymis protein 4 compared with
mesothelin for ovarian cancer: a systematic review and
meta-analysis. Asian Pac J Cancer Prev. 13:5427–5432. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou J, Ng AY, Tymms MJ, Jermiin LS, Seth
AK, Thomas RS and Kola I: A novel transcription factor, ELF5,
belongs to the ELF subfamily of ETS genes and maps to human
chromosome 11p13-15, a region subject to LOH and rearrangement in
human carcinoma cell lines. Oncogene. 17:2719–2732. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi YS and Sinha S: Determination of the
consensus DNA-binding sequence and a transcriptional activation
domain for ESE-2. Biochem J. 398:497–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prat J: FIGO Committee on Gynecologic
Oncology: Staging classification for cancer of the ovary, fallopian
tube, and peritoneum. Int J Gynaecol Obstet. 124:1–5. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He J, Pan Y, Hu J, Albarracin C, Wu Y and
Dai JL: Profile of Ets gene expression in human breast carcinoma.
Cancer Biol Ther. 6:76–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee HJ and Ormandy CJ: Elf5, hormones and
cell fate. Trends Endocrinol Metab. 23:292–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lapinskas EJ, Palmer J, Ricardo S, Hertzog
PJ, Hammacher A and Pritchard MA: A major site of expression of the
ets transcription factor Elf5 is epithelia of exocrine glands.
Histochem Cell Biol. 122:521–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hemberger M, Udayashankar R, Tesar P,
Moore H and Burton GJ: ELF5-enforced transcriptional networks
define an epigenetically regulated trophoblast stem cell
compartment in the human placenta. Hum Mol Genet. 19:2456–2467.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee HJ, Gallego-Ortega D, Ledger A,
Schramek D, Joshi P, Szwarc MM, Cho C, Lydon JP, Khokha R,
Penninger JM, et al: Progesterone drives mammary secretory
differentiation via RankL-mediated induction of Elf5 in luminal
progenitor cells. Development. 140:1397–1401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lapinskas EJ, Svobodova S, Davis ID, Cebon
J, Hertzog PJ and Pritchard MA: The Ets transcription factor ELF5
functions as a tumor suppressor in the kidney. Twin Res Hum Genet.
14:316–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pearton DJ, Smith CS, Redgate E, van
Leeuwen J, Donnison M and Pfeffer PL: Elf5 counteracts precocious
trophoblast differentiation by maintaining Sox2 and 3 and
inhibiting Hand1 expression. Dev Biol. 392:344–357. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee HJ, Hinshelwood RA, Bouras T,
Gallego-Ortega D, Valdés-Mora F, Blazek K, Visvader JE, Clark SJ
and Ormandy CJ: Lineage specific methylation of the Elf5 promoter
in mammary epithelial cells. Stem Cells. 29:1611–1619. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chakrabarti R, Wei Y, Romano RA, DeCoste
C, Kang Y and Sinha S: Elf5 regulates mammary gland stem/progenitor
cell fate by influencing notch signaling. Stem Cells. 30:1496–1508.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chakrabarti R, Hwang J, Blanco M Andres,
Wei Y, Lukačišin M, Romano RA, Smalley K, Liu S, Yang Q, Ibrahim T,
et al: Elf5 inhibits the epithelial-mesenchymal transition in
mammary gland development and breast cancer metastasis by
transcriptionally repressing Snail2. Nat Cell Biol. 14:1212–1222.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalyuga M, Gallego-Ortega D, Lee HJ, Roden
DL, Cowley MJ, Caldon CE, Stone A, Allerdice SL, Valdes-Mora F,
Launchbury R, et al: ELF5 suppresses estrogen sensitivity and
underpins the acquisition of antiestrogen resistance in luminal
breast cancer. PLoS Biol. 10:e10014612012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frend HT and Watson CJ: Elf5 - breast
cancer's little helper. Breast Cancer Res. 15:3072013. View Article : Google Scholar : PubMed/NCBI
|
